Treatment of respiratory syncytial virus with palivizumab: a systematic review

Overview of attention for article published in World Journal of Pediatrics, November 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#34 of 587)
High Attention Score compared to outputs of the same age (89th percentile)

Mentioned by

patent: 3 patents

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 68 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Dimensions has found 41 publications that cite this research output.

41

The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.

Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and Meta-Analysis

Article in Cureus (December 2023)

Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection

Article in Cochrane Database of Systematic Reviews (October 2023)

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus

Article in Proceedings of the National Academy of Sciences of the United States of America (August 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.